Page 65 - Read Online

Calderon Novoa et al. Hepatoma Res 2023;9:33 https://dx.doi.org/10.20517/2394-5079.2023.36 Page 11 of 11

63. Rayar M, Levi Sandri GB, Houssel-Debry P, Camus C, Sulpice L, Boudjema K. Multimodal therapy including Yttrium-90
radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma. J
Gastrointestin Liver Dis 2016;25:401-4. DOI PubMed
64. Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar
cholangiocarcinoma: a 24-year experience in a single center. Arch Surg 2011;146:683-9. DOI
65. Ito T, Butler JR, Noguchi D, et al. A 3-Decade, single-center experience of liver transplantation for cholangiocarcinoma: impact of era,
tumor size, location, and neoadjuvant therapy. Liver Transpl 2022;28:386-96. DOI
66. Lunsford KE, Javle M, Heyne K, et al; Methodist0-MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC).
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
Lancet Gastroenterol Hepatol 2018;3:337-48. DOI
67. McMillan RR, Javle M, Kodali S, et al. Survival following liver transplantation for locally advanced, unresectable intrahepatic
cholangiocarcinoma. Am J Transplant 2022;22:823-32. DOI
68. Nakachi K, Ikeda M, Konishi M, et al; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-
HBPOG). Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label,
randomised, controlled, phase 3 trial. Lancet 2023;401:195-203. DOI
69. Hu LS, Zhang XF, Weiss M, et al. Recurrence patterns and timing courses following curative-intent resection for intrahepatic
cholangiocarcinoma. Ann Surg Oncol 2019;26:2549-57. DOI
70. Tsilimigras DI, Sahara K, Wu L, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering
alternative treatment approaches. JAMA Surg 2020;155:823-31. DOI PubMed PMC
71. Doussot A, Gonen M, Wiggers JK, et al. Recurrence patterns and disease-free survival after resection of intrahepatic
cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 2016;223:493-505.e2. DOI PubMed PMC
72. Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int 2019;39 Suppl 1:19-31. DOI PubMed
73. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-84. DOI PubMed PMC
74. Hyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma:
an Eastern and Western experience. JAMA Surg 2014;149:432-8. DOI
75. Sahara K, Tsilimigras DI, Mehta R, et al. A novel online prognostic tool to predict long-term survival after liver resection for
intrahepatic cholangiocarcinoma: the "metro-ticket" paradigm. J Surg Oncol 2019;120:223-30. DOI
76. Choi WJ, Perez FM, Gravely A, et al. Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative
intrahepatic cholangiocarcinoma resection. Ann Hepatobiliary Pancreat Surg 2023;27:158-65. DOI PubMed PMC
77. Bo Z, Chen B, Yang Y, et al. Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after
curative resection: a multicentre cohort study. Eur J Nucl Med Mol Imaging 2023;50:2501-13. DOI
78. Alaimo L, Lima HA, Moazzam Z, et al. ASO visual abstract: development and validation of a machine learning model to predict early
recurrence of intrahepatic cholangiocarcinoma. Ann Surg Oncol 2023:Online ahead of print. DOI
79. Chu H, Liu Z, Liang W, et al. Radiomics using CT images for preoperative prediction of futile resection in intrahepatic
cholangiocarcinoma. Eur Radiol 2021;31:2368-76. DOI
80. Vallin M, Sturm N, Lamblin G, et al. Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants.
Clin Transplant 2013;27:403-9. DOI
81. Lindnér P, Rizell M, Hafström L. The impact of changed strategies for patients with cholangiocarcinoma in this millenium. HPB Surg
2015;2015:736049. DOI PubMed PMC
82. Facciuto ME, Singh MK, Lubezky N, et al. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes
after liver transplantation. Transplantation 2015;99:151-7. DOI
83. Jung DH, Hwang S, Song GW, et al. Clinicopathological features and prognosis of intrahepatic cholangiocarcinoma after liver
transplantation and resection. Ann Transplant 2017;22:42-52. DOI
84. Lee DD, Croome KP, Musto KR, et al. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl 2018;24:634-44. DOI
85. Krasnodębski M, Grąt M, Jastrzębski M, et al. Unsatisfactory long-term results of liver transplant in patients with intrahepatic
cholangiocarcinoma. Transplant Proc 2020;52:2463-7. DOI